Published in J Clin Endocrinol Metab on August 01, 1997
Oral T7 Oral Testosterone in Man (Oral T7) | NCT00842751
ORAL T-8 Oral Testosterone for Male Hormonal Contraception (Oral T8) | NCT01167829
The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag (2009) 1.90
Osteoporosis in men. Endocr Rev (2008) 1.80
Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels. J Clin Endocrinol Metab (2009) 1.78
In vivo microMRI-based finite element and morphological analyses of tibial trabecular bone in eugonadal and hypogonadal men before and after testosterone treatment. J Bone Miner Res (2008) 1.40
Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. Nat Rev Endocrinol (2015) 1.39
Advances in male contraception. Endocr Rev (2008) 1.39
Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int (2011) 1.33
Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats. Endocrinology (2005) 1.27
Estrogens as regulators of bone health in men. Nat Rev Endocrinol (2009) 1.26
Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy. Int J Endocrinol (2012) 1.18
Androgens and bone. Steroids (2008) 1.05
Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr Rev (2012) 1.01
Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Osteoporos Int (2010) 0.99
Hormone treatments and preventive strategies in the aging male: whom and when to treat? Rev Urol (2003) 0.99
Testosterone for the aging male; current evidence and recommended practice. Clin Interv Aging (2008) 0.98
Sex hormones, their receptors and bone health. Osteoporos Int (2008) 0.94
Aetiology, diagnosis, and management of hypopituitarism in adult life. Postgrad Med J (2006) 0.93
Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men. Osteoporos Int (2005) 0.91
Serum testosterone, sex hormone-binding globulin and total calcium levels predict the calcaneal speed of sound in men. Clinics (Sao Paulo) (2012) 0.90
Causes, consequences, and treatment of osteoporosis in men. Drug Des Devel Ther (2013) 0.87
Comparison of dried plum supplementation and intermittent PTH in restoring bone in osteopenic orchidectomized rats. Osteoporos Int (2007) 0.86
Correlates of trabecular and cortical volumetric bone mineral density of the radius and tibia in older men: the Osteoporotic Fractures in Men Study. J Bone Miner Res (2010) 0.86
Testosterone replacement in men with andropause: an overview. Rev Urol (2004) 0.84
Testosterone replacement and bone mineral density in male pituitary tumor patients. Endocrinol Metab (Seoul) (2014) 0.84
Management of endocrine disease: Secondary osteoporosis: pathophysiology and management. Eur J Endocrinol (2015) 0.83
Testosterone increases bone mineral density in female-to-male transsexuals: a case series of 15 subjects. Clin Endocrinol (Oxf) (2004) 0.83
Andropause. Testosterone replacement therapy for aging men. Can Fam Physician (2001) 0.82
Osteoporosis in men. J R Soc Med (2001) 0.82
Effects of short-term testosterone replacement on areal bone mineral density and bone turnover in young hypogonadal males. Indian J Endocrinol Metab (2012) 0.81
A study of male patients with forearm fracture in Northern Ireland. Clin Rheumatol (2006) 0.81
Male hormonal contraception. Virtual Mentor (2012) 0.81
Bone mineral density in survivors of childhood brain tumours. Childs Nerv Syst (2006) 0.81
Background for studies on the treatment of male osteoporosis: state of the art. Ann Rheum Dis (2000) 0.80
Bone health and associated metabolic complications in neuromuscular diseases. Phys Med Rehabil Clin N Am (2012) 0.80
An update on male hypogonadism therapy. Expert Opin Pharmacother (2014) 0.80
Effects of vitamin K2 on the development of osteopenia in rats as the models of osteoporosis. Yonsei Med J (2006) 0.79
Anorexia nervosa - medical complications. J Eat Disord (2015) 0.79
Osteoporosis in men: insights for the clinician. Ther Adv Musculoskelet Dis (2011) 0.79
Androgen therapy in the aging male. World J Urol (2003) 0.79
Testosterone replacement therapy and bone mineral density in men with hypogonadism. Endocrinol Metab (Seoul) (2014) 0.78
Genetic and hormonal control of bone volume, architecture, and remodeling in XXY mice. J Bone Miner Res (2010) 0.78
Sex hormones in Malay and Chinese men in Malaysia: are there age and race differences? Clinics (Sao Paulo) (2013) 0.78
Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study. PLoS One (2015) 0.77
Androgens and male aging: Current evidence of safety and efficacy. Asian J Androl (2010) 0.77
Androgen replacement therapy in the aging male. Rev Urol (2003) 0.76
7α-methyl-19-nortestosterone vs. testosterone implants for hypogonadal osteoporosis: a preclinical study in the aged male orchidectomized rat model. Int J Androl (2011) 0.76
Testosterone replacement and prostate cancer. Indian J Urol (2012) 0.76
Progressive Improvement of T-Scores in Men with Osteoporosis and Subnormal Serum Testosterone Levels upon Treatment with Testosterone over Six Years. Int J Endocrinol (2014) 0.76
The osteoporotic male: overlooked and undermanaged? Clin Interv Aging (2007) 0.76
Recent topics related to testosterone deficiency syndrome in Japan. Asian J Androl (2011) 0.76
Androgen receptor agonism promotes an osteogenic gene program in preadipocytes. Biochem Biophys Res Commun (2013) 0.76
Male hormonal contraception: looking back and moving forward. Andrology (2015) 0.76
Treatments of medical complications of anorexia nervosa and bulimia nervosa. J Eat Disord (2015) 0.76
Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial. JAMA Intern Med (2017) 0.75
In vitro and in vivo evaluation of a novel testosterone transdermal delivery system (TTDS) using palm oil base. Iran J Basic Med Sci (2015) 0.75
Male Hypogonadism and Osteoporosis: The Effects, Clinical Consequences, and Treatment of Testosterone Deficiency in Bone Health. Int J Endocrinol (2017) 0.75
Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone. Biomed Res Int (2015) 0.75
Exploratory analysis of the potential relationship between urinary molybdenum and bone mineral density among adult men and women from NHANES 2007-2010. Chemosphere (2016) 0.75
A Case of Male Osteoporosis: A 37-Year-Old Man with Multiple Vertebral Compression Fractures. Case Rep Endocrinol (2017) 0.75
A method for producing specific antisera with small doses of immunogen. J Clin Endocrinol Metab (1971) 4.38
Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet (1996) 3.78
In vivo T(1rho) and T(2) mapping of articular cartilage in osteoarthritis of the knee using 3 T MRI. Osteoarthritis Cartilage (2007) 3.56
Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell (1995) 2.89
Lifespan and testosterone. Nature (1993) 2.84
Pedicle screw instrumentation of the thoracic spine in idiopathic scoliosis. Spine (Phila Pa 1976) (1997) 2.67
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
Severe impairment of spermatogenesis in mice lacking the CREM gene. Nature (1996) 2.63
The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev (1997) 2.44
Proposal for a nomenclature for magnetic resonance imaging based measures of articular cartilage in osteoarthritis. Osteoarthritis Cartilage (2006) 2.29
Episodic variations of prolactin, thyroid-stimulating hormone, luteinizing hormone, melatonin and cortisol in infertile women with subclinical hypothyroidism. Hum Reprod (1997) 2.23
Current status of the molecular diagnosis of Y-chromosomal microdeletions in the work-up of male infertility. Initiative for international quality control. Hum Reprod (1998) 2.10
Y-chromosome microdeletions are not associated with SHOX haploinsufficiency. Hum Reprod (2013) 2.01
Organ sparing surgery for malignant germ cell tumor of the testis. J Urol (2001) 1.99
Creatine kinase activity in human spermatozoa and seminal plasma lacks predictive value for male fertility in in vitro fertilization. Fertil Steril (1998) 1.98
Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements. Hum Reprod (2000) 1.96
Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR Am J Roentgenol (1998) 1.94
Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol (2001) 1.66
External quality control in the andrology laboratory: an experimental multicenter trial. Fertil Steril (1990) 1.65
Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod (1999) 1.61
Enzymatic radioiodination of gonadotropins. J Clin Endocrinol Metab (1972) 1.61
Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab (2000) 1.60
MRI-derived T2 relaxation times and cartilage morphometry of the tibio-femoral joint in subjects with and without osteoarthritis during a 1-year follow-up. Osteoarthritis Cartilage (2007) 1.59
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol (2008) 1.55
Cryopreservation of semen from adolescent patients with malignancies. Med Pediatr Oncol (1996) 1.53
Deletion of azoospermia factor a (AZFa) region of human Y chromosome caused by recombination between HERV15 proviruses. Hum Mol Genet (2000) 1.53
Morphometric analysis of thoracic and lumbar vertebrae in idiopathic scoliosis. Spine (Phila Pa 1976) (2000) 1.51
Precision of 3.0 Tesla quantitative magnetic resonance imaging of cartilage morphology in a multicentre clinical trial. Ann Rheum Dis (2008) 1.50
Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil Steril (1995) 1.45
Sonographic testicular microlithiasis as an indicator of premalignant conditions in normal and infertile men. J Androl (2001) 1.45
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol (2012) 1.44
Cartilage and meniscus assessment using T1rho and T2 measurements in healthy subjects and patients with osteoarthritis. Osteoarthritis Cartilage (2010) 1.43
Objective identification of hyperactivated human spermatozoa by computerized sperm motion analysis with the Hamilton-Thorn sperm motility analyser. Hum Reprod (1990) 1.42
A portable digital data recorder for long-term monitoring of scrotal temperatures. Fertil Steril (1990) 1.42
Subjects with higher physical activity levels have more severe focal knee lesions diagnosed with 3T MRI: analysis of a non-symptomatic cohort of the osteoarthritis initiative. Osteoarthritis Cartilage (2010) 1.42
The epididymis and male fertility. A symposium report. Int J Androl (1986) 1.41
The effect of bradykinin and the bradykinin antagonist Hoe 140 on kinematic parameters of human spermatozoa. Int J Androl (1996) 1.40
[Tumorous space-occupying lesion of the ilium]. Radiologe (1995) 1.39
[The Kallmann syndrome. Its pathophysiology and clinical picture]. Dtsch Med Wochenschr (1994) 1.39
Change in regional cartilage morphology and joint space width in osteoarthritis participants versus healthy controls: a multicentre study using 3.0 Tesla MRI and Lyon-Schuss radiography. Ann Rheum Dis (2010) 1.38
Feasibility of in vivo structural analysis of high-resolution magnetic resonance images of the proximal femur. Osteoporos Int (2005) 1.38
Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet (1997) 1.38
Reversible azoospermia induced by the anabolic steroid 19-nortestosterone. Lancet (1984) 1.36
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl (2008) 1.31
Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update (2002) 1.30
Germ cell transfer into rat, bovine, monkey and human testes. Hum Reprod (1999) 1.30
Trabecular bone architecture in the distal radius using magnetic resonance imaging in subjects with fractures of the proximal femur. Magnetic Resonance Science Center and Osteoporosis and Arthritis Research Group. Osteoporos Int (1999) 1.30
Testosterone levels in healthy men and the relation to behavioural and physical characteristics: facts and constructs. Eur J Endocrinol (2001) 1.30
Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate. Acta Endocrinol (Copenh) (1975) 1.26
Germ cell transplantation into X-irradiated monkey testes. Hum Reprod (2002) 1.25
Partial deletions in the AZFc region of the Y chromosome occur in men with impaired as well as normal spermatogenesis. Hum Reprod (2004) 1.24
Subregional femorotibial cartilage morphology in women--comparison between healthy controls and participants with different grades of radiographic knee osteoarthritis. Osteoarthritis Cartilage (2009) 1.24
Inhibin B in male reproduction: pathophysiology and clinical relevance. Eur J Endocrinol (2001) 1.24
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Impot Res (2008) 1.22
High-resolution magnetic resonance imaging: three-dimensional trabecular bone architecture and biomechanical properties. Bone (1998) 1.21
The feasibility of characterizing the spatial distribution of cartilage T(2) using texture analysis. Osteoarthritis Cartilage (2008) 1.20
Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab (1999) 1.20
Periosteal chondroma: MR characteristics. J Comput Assist Tomogr (2001) 1.19
Head-to-head comparison of the Lyon Schuss and fixed flexion radiographic techniques. Long-term reproducibility in normal knees and sensitivity to change in osteoarthritic knees. Ann Rheum Dis (2008) 1.18
Objective measurement of testicular volume by ultrasonography: evaluation of the technique and comparison with orchidometer estimates. Int J Androl (1989) 1.17
Reproductive functions in young fathers and grandfathers. J Clin Endocrinol Metab (1982) 1.17
T₁ρ and T₂ relaxation times predict progression of knee osteoarthritis. Osteoarthritis Cartilage (2012) 1.14
Cartilage and meniscal T2 relaxation time as non-invasive biomarker for knee osteoarthritis and cartilage repair procedures. Osteoarthritis Cartilage (2013) 1.14
The structure and organization of the human follicle-stimulating hormone receptor (FSHR) gene. Genomics (1996) 1.14
Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 1,186 infertile women. Fertil Steril (2000) 1.14
T1rho relaxation time of the meniscus and its relationship with T1rho of adjacent cartilage in knees with acute ACL injuries at 3 T. Osteoarthritis Cartilage (2008) 1.13
Assessment of trabecular bone structure comparing magnetic resonance imaging at 3 Tesla with high-resolution peripheral quantitative computed tomography ex vivo and in vivo. Osteoporos Int (2007) 1.12
The effects of acute loading on T1rho and T2 relaxation times of tibiofemoral articular cartilage. Osteoarthritis Cartilage (2010) 1.12
First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males. Hum Reprod (2001) 1.12
Experience with external quality control in spermatology. Hum Reprod (1999) 1.11
Steroid hormones and their binding in plasma of male patients with fatty liver, chronic hepatitis and liver cirrhosis. Acta Endocrinol (Copenh) (1975) 1.11
Phenotypic variation within European carriers of the Y-chromosomal gr/gr deletion is independent of Y-chromosomal background. J Med Genet (2008) 1.10
Performance of a non-fluoroscopically assisted substitute for the Lyon schuss knee radiograph: quality and reproducibility of positioning and sensitivity to joint space narrowing in osteoarthritic knees. Osteoarthritis Cartilage (2008) 1.10
The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia (2002) 1.10
Baseline mean and heterogeneity of MR cartilage T2 are associated with morphologic degeneration of cartilage, meniscus, and bone marrow over 3 years--data from the Osteoarthritis Initiative. Osteoarthritis Cartilage (2012) 1.09
A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab (2005) 1.09
Vastus lateralis/vastus medialis cross-sectional area ratio impacts presence and degree of knee joint abnormalities and cartilage T2 determined with 3T MRI - an analysis from the incidence cohort of the Osteoarthritis Initiative. Osteoarthritis Cartilage (2010) 1.08
Association of cartilage defects, and other MRI findings with pain and function in individuals with mild-moderate radiographic hip osteoarthritis and controls. Osteoarthritis Cartilage (2013) 1.07
Semen analysis and external quality control schemes for semen analysis need global standardization. Int J Androl (2002) 1.06
Clinical experience with azoospermia: aetiology and chances for spermatozoa detection upon biopsy. Int J Androl (2010) 1.06
Evaluation of the semi-automated Autosperm semen analysis system. I. Accuracy and comparison with the conventional method and the automated Hamilton-Thorn system. Fertil Steril (1990) 1.06
A novel fast knee cartilage segmentation technique for T2 measurements at MR imaging--data from the Osteoarthritis Initiative. Osteoarthritis Cartilage (2011) 1.06
Spontaneous recrudescence of spermatogenesis in the photoinhibited male Djungarian hamster, Phodopus sungorus. Biol Reprod (1995) 1.06
Serum FSH and testicular morphology in male infertility. Clin Endocrinol (Oxf) (1994) 1.05
Ricin A-chain: kinetics, mechanism, and RNA stem-loop inhibitors. Biochemistry (1998) 1.05
Screening for deletions of the Y chromosome involving the DAZ (Deleted in AZoospermia) gene in azoospermia and severe oligozoospermia. Fertil Steril (1997) 1.05
Anabolic steroids and semen parameters in bodybuilders. Fertil Steril (1989) 1.04
Cartilage morphology and T1ρ and T2 quantification in ACL-reconstructed knees: a 2-year follow-up. Osteoarthritis Cartilage (2013) 1.04
The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity. J Clin Endocrinol Metab (2001) 1.04
Structural analysis of trabecular bone of the proximal femur using multislice computed tomography: a comparison with dual X-ray absorptiometry for predicting biomechanical strength in vitro. Calcif Tissue Int (2006) 1.03
Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. Pediatr Radiol (1998) 1.03
Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years. Clin Endocrinol (Oxf) (1999) 1.03
Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab (2000) 1.03
An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J Clin Endocrinol Metab (1996) 1.03
Developmental expression of the pluripotency factor sal-like protein 4 in the monkey, human and mouse testis: restriction to premeiotic germ cells. Cells Tissues Organs (2012) 1.02
Influence of short photoperiods on reproductive organs and estrous cycles of normal and pinealectomized female Djungarian hamsters, Phodopus sungorus. Biol Reprod (1993) 1.02